This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Description, Dosage, Side Effects, Contraindications. Data from EMA, URPL, openFDA and other regulatory sources.
| Sitagliptin | Metformin | |
|---|---|---|
| Active Substances | SITAGLIPTIN | METFORMIN HYDROCHLORIDE |
| ATC Code | A10BH01 | A10BA02 |
| Form | SOLUTION | — |
| Dosage | 25 mg/mL | — |
| Route | ORAL | — |
| Manufacturer | Azurity Pharmaceuticals, Inc. | APOTEX INC |
| Indications | Sitagliptin is indicated to improve glucose control in adults with type 2 diabetes mellitus along with diet and exercise. | — |
| Side Effects | Metabolic - Low blood sugar with other medications. Central Nervous System - Headache. Eye and ENT - Inflammation of nasopharynx. Gastrointestinal - Diarrhea, nausea, inflammation of pancreas. Respiratory - Upper respiratory tract infection. Musculoskeletal -Joint pain, muscle pain, pain in extremity and back pain. |
Sitagliptin (INN: SITAGLIPTIN, ATC A10BH01) and Metformin (INN: METFORMIN HYDROCHLORIDE, ATC A10BA02) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
| — |
| Warnings | •1. Avoid alcohol consumption while taking Sitagliptin • 2. Sitagliptin may lead to low blood sugar, monitor blood sugar regularly. | — |
|---|